What can we expect about the costs of the expansion and viral vector plant? Will the equipment be depreciated over its life? What about labor and other costs? Have they all been accounted for already? What kind of bump in eps can we expect due to the decrease in expenses that have already been accounted for?
News 
Market Data 
Discover 
AI
